/ /

Lynda Charters
Extensive analysis confirms treat-and-extend regimens reliable for AMD
In patients with age-related macular degeneration managed by a treat-and-extend regimen, the visual acuity generally was maintained; lesion reactivation occurred frequently at about eight weeks; and longer induction phases between treatments was associated with worse outcomes.
Investigating strains on ONH tissue key to unraveling mystery of glaucoma
Investigations of the biomechanical changes in the optic nerve head may eventually lead to improvements in therapies for patients with glaucoma.
Ultra-widefield angiography: New window for retinovascular features
Quantitative assessment of retinovascular features on ultra-widefield angiography images showed significant improvements in leakage and ischemia following treatment with aflibercept in patients with diabetic macular edema and retinal vein occlusion.
Contrast sensitivity device exposes vision limitations of reattachment patients
Computerized testing of contrast sensitivity function using the Sentio Platform (Adaptive Sensory Technology) may better quantify the visual limitations of patients than traditional letter acuity after retinal detachment repair.
Vitrectomy with brachytherapy shows no increase in metastatic risk
The metastatic prognosis does not increase when vitrectomy is performed at the time of brachytherapy.
Subretinal therapy offers promise of lighter treatment burden for AMD
RGX-314 gene therapy offers patients the potential for a lower treatment burden with one subretinal injection of a gene therapy delivering an anti-vascular endothelial growth factor protein.
OCTA: Future Is bright, fast, and wide in ROP
Advances in optical coherence tomography (OCT) and OCT angiography (OCTA) may enable more objective and accurate diagnosis of ROP in the future.
Phase IV study shows improved DME outcomes with fluocinolone acetonide implant
The fluocinolone acetonide 0.2 mcg/day implant (Iluvien, Alimera Sciences) offers an additional option for treating diabetic macular edema that reduces the need for subsequent therapy with anti-vascular endothelial growth factor or steroid treatment.
Povidone iodine reapplication: Protocol for preventing endophthalmitis
Take-Home Message: A pearl for preventing endophthalmitis following intravitreal injections: avoid eyelid contact with the injection site after the last application of povidone iodine.


View Results